Reports Q1 revenue $7.6M vs $54,990 last year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LPCN:
- Lipocine completes dosing in study of postpartum depression candidate LPCN 1154
- Lipocine Initiates New ATM Offering, Ends Previous Agreement
- Lipocine’s LPCN 2401 shows positive Phase 2 results in obesity trial
- Lipocine’s LPCN 1148 shows positive results in Phase 2 cirrhosis study
- Lipocine announces first cohort dosed in LPCN 1154